Resolvyx Pharmaceuticals Garners $4,000,000 Series B Financing

  • Feed Type
  • Date
    8/22/2008
  • Company Name
    Resolvyx Pharmaceuticals
  • Mailing Address
    6A Preston Court Bedford, MA 01730
  • Company Description
    Resolvyx is a biopharmaceutical company committed to the discovery and development of therapies based on the novel concept of inflammation resolution through activation of the body’s own off-switch mechanisms.
  • Website
    '>http://www.resolvyx.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from the financing will be used to accelerate the development of Resolvyx’s preclinical pipeline and to advance multiple resolvin drug candidates into clinical trials in 2008.
  • M&A Terms
  • Venture Investor
    QVT Fund LP
  • Venture Investor
    Atlas Venture
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    Radius Ventures
  • Venture Investor
    CHL Medical Partners
  • Venture Investor
    Biogen Idec Inc.

By posting a comment, you agree to our terms and conditions.